Inner Mongolia Anzhou Pharmaceutical Intermediates Reconstruction and Expansion Project Filing (Sallafloxacin Hydrochloride, Dimenidazole, Gatifloxacin Mesylate) project plans to invest 20 million yuan to transform the proimidazoaldehyde production line to produce dimetronidazole; increase part of the equipment for the production of salfloxacin hydrochloride and gatifloxacin mesylate; After the transformation is completed, it can produce 150 tons/year of simvastatin ammonium salt; Demenidazole 200 tons/year; Salfloxacin hydrochloride 200 tons/year; Gatifloxacin mesylate 200 tons/year.
